Rybelsus (semaglutide) is approved for Type 2 diabetes and comes in 3 mg, 7 mg, and 14 mg tablets. But higher Rybelsus doses (25 mg and 50 mg) are being studied for weight loss. According to findings from the OASIS 4 clinical trial, a 25 mg Rybelsus dose resulted in weight loss that was comparable to the highest Wegovy dose. Due to these promising results, higher Rybelsus doses could be approved for weight loss in the future.
View original source